Youmanitarian
Youmanitarian 11 Jun 2021

Hasta la próxima

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 12 vistas

Olaparib in Ovarian Cancer

16 vistas
TAKE ACTION
Donations would go to support charities for Cómo hacer y estilo

In this segment, Bradley J. Monk, MD; Robert L. Coleman, MD; and Angeles Alvarez Secord, MD, examine the role of poly-ADP ribose polymerase (PARP) inhibitor, olaparib, in the treatment of advanced ovarian cancer.

Mostrar más
More ways to take action
Explore ways that you can help bring a solution to this issue.

Hasta la próxima

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 12 vistas